271 results Wetsvoorstel opheffing verpandingsverboden: (mogelijke) impact op de financieringspraktijk Het op 2/6/2020 bij de Tweede Kamer ingediende wetsvoorstel opheffing verpandingsverboden beoogt de bestaande praktijk van het contractueel overeenkomen van verboden of beperkingen van de overdracht of verpanding van geldvorderingen op naam op te heffen. Stibbe advises Astorg and IQ-EQ Stibbe advised Astorg and IQ-EQ with the acquisition of Blue River Partners. Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare. Stibbe advises Aedifica Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Dordrecht and the acquisitions and leases of recently completed healthcare residences in Harderwijk and Berkel-Enschot (NL). Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health. Bill of law on interest and royalties paid to non-cooperative jurisdictions The Luxembourg Government proposes to introduce the non-deductibility of interest and royalties expenses of a Luxembourg taxpayer towards collective entities located in a blacklisted jurisdiction. Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types. Breaking news from the CJEU: no SPCs for new therapeutic applications On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products. Stibbe advises Rhône Group and The Chatterjee Group Stibbe advised private equity firm Rhône Group and The Chatterjee Group on the joint acquisition of McDermott International, Inc.’s Lummus Technology Group. Le chômage temporaire est-il antidote au coronavirus? L’ONEM a confirmé que les employeurs peuvent, dans certaines situations, mettre des travailleurs en chômage temporaire pour force majeure en raison du coronavirus. Contracts & Corona: force majeure and related topics The spread of the coronavirus may have some consequences that affect your ability to perform your obligations under your contracts, or your co-contractors’ ability to perform theirs. We provide some insight on a few pressing questions. Luxembourg adopts measures to facilitate holding of meetings in companies and other legal entities during Covid-19” Luxembourg adopted a Grand-Ducal Regulation on 20 March 2020 introducing emergency measures relating to the holding of meetings in companies and other legal entities. Jeroen Kortmann nominated for best Dutch litigator For the second consecutive year, Jeroen Kortmann has been nominated for the title of 'best Dutch litigator'. Stibbe advises Partners Group Stibbe advised Partners Group on the sale of its stake in Action, Europe's leading non-food discount retailer, to Hellman & Friedman, a leading private equity investment firm. Stibbe advises Olympia and Avedon Capital Partners Stibbe advised Olympia and Avedon Capital Partners on the sale of the majority stake of Avedon Capital Partners in Olympia to Olympia’s CEO Dimitri Yocarini and Morgan Stanley Tactical Value Investing. Stibbe advises Aedifica Stibbe advised Aedifica on its secondary share listing on Euronext Amsterdam. Trading started on 7 November 2019. Stibbe advises Wright Medical Group Stibbe is advising Wright Medical Group on the offer from Stryker to acquire Wright Medical Group. 2020: Het jaar van het multilateraal instrument? - Column Fondsnieuws Het multilateraal instrument (MLI) is een van de belangrijkste fiscale ontwikkelingen van het moment. In een column voor Fondsnieuws bespreekt David de Groot de (potentiële) gevolgen die het MLI voor beleggingsfondsen kan hebben. Pagination Previous page Page 4 Current page 5 Page 6 Page 7 Next page
Wetsvoorstel opheffing verpandingsverboden: (mogelijke) impact op de financieringspraktijk Het op 2/6/2020 bij de Tweede Kamer ingediende wetsvoorstel opheffing verpandingsverboden beoogt de bestaande praktijk van het contractueel overeenkomen van verboden of beperkingen van de overdracht of verpanding van geldvorderingen op naam op te heffen.
Stibbe advises Astorg and IQ-EQ Stibbe advised Astorg and IQ-EQ with the acquisition of Blue River Partners.
Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare.
Stibbe advises Aedifica Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Dordrecht and the acquisitions and leases of recently completed healthcare residences in Harderwijk and Berkel-Enschot (NL).
Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.
Bill of law on interest and royalties paid to non-cooperative jurisdictions The Luxembourg Government proposes to introduce the non-deductibility of interest and royalties expenses of a Luxembourg taxpayer towards collective entities located in a blacklisted jurisdiction.
Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types.
Breaking news from the CJEU: no SPCs for new therapeutic applications On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products.
Stibbe advises Rhône Group and The Chatterjee Group Stibbe advised private equity firm Rhône Group and The Chatterjee Group on the joint acquisition of McDermott International, Inc.’s Lummus Technology Group.
Le chômage temporaire est-il antidote au coronavirus? L’ONEM a confirmé que les employeurs peuvent, dans certaines situations, mettre des travailleurs en chômage temporaire pour force majeure en raison du coronavirus.
Contracts & Corona: force majeure and related topics The spread of the coronavirus may have some consequences that affect your ability to perform your obligations under your contracts, or your co-contractors’ ability to perform theirs. We provide some insight on a few pressing questions.
Luxembourg adopts measures to facilitate holding of meetings in companies and other legal entities during Covid-19” Luxembourg adopted a Grand-Ducal Regulation on 20 March 2020 introducing emergency measures relating to the holding of meetings in companies and other legal entities.
Jeroen Kortmann nominated for best Dutch litigator For the second consecutive year, Jeroen Kortmann has been nominated for the title of 'best Dutch litigator'.
Stibbe advises Partners Group Stibbe advised Partners Group on the sale of its stake in Action, Europe's leading non-food discount retailer, to Hellman & Friedman, a leading private equity investment firm.
Stibbe advises Olympia and Avedon Capital Partners Stibbe advised Olympia and Avedon Capital Partners on the sale of the majority stake of Avedon Capital Partners in Olympia to Olympia’s CEO Dimitri Yocarini and Morgan Stanley Tactical Value Investing.
Stibbe advises Aedifica Stibbe advised Aedifica on its secondary share listing on Euronext Amsterdam. Trading started on 7 November 2019.
Stibbe advises Wright Medical Group Stibbe is advising Wright Medical Group on the offer from Stryker to acquire Wright Medical Group.
2020: Het jaar van het multilateraal instrument? - Column Fondsnieuws Het multilateraal instrument (MLI) is een van de belangrijkste fiscale ontwikkelingen van het moment. In een column voor Fondsnieuws bespreekt David de Groot de (potentiële) gevolgen die het MLI voor beleggingsfondsen kan hebben.